Document Detail

Intracoronary transplantation of genetically modified mesenchymal stem cells, a novel method to close muscular ventricular septal defects.
MedLine Citation:
PMID:  21788104     Owner:  NLM     Status:  Publisher    
Muscular ventricular septal defects remain a challenge despite the progress in surgical and interventional closure of ventricular septal defects. Our hypothesis was inspired by the fact that more than two thirds of children with muscular ventricular septal defects experienced spontaneous closure. Therefore, we intend to induce the spontaneous closure of muscular ventricular septal defects by means of targeted intracoronary injection of mesenchymal stem cells which are genetically modified to enhance myocardial hypertrophy. The transplantation of bone marrow derived cells has been observed to be effective in improving tissue recovery and ameliorating cardiac function in patients and animal models with ischemic heart disease, acute myocarditis and dilated cardiomyopathy. We expect that the targeted intracoronary transplantation of genetically modified mesenchymal stem cells could enhance the tissue generation and myocardial hypertrophy simultaneously, which may lead to the closure of muscular ventricular septal defects in a way that imitate the spontaneous closure of ventricular septal defects.
Qing Yang; Juqian Zhang; Jian Jiang
Related Documents :
19435734 - Isolated left atrial appendage ostial stenosis.
8839814 - Co-existence of atrial tachycardia and common atrial flutter: electrophysiological char...
11707684 - Electropharmacologic effects of pilsicainide, a pure sodium channel blocker, on the rem...
6241884 - Distribution of myosin isozymes in human atrial and ventricular myocardium: comparison ...
21844794 - P53 codon 72 polymorphism and coronary artery disease: evidence of association with lef...
20126594 - Congenital short qt syndrome.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-7-23
Journal Detail:
Title:  Medical hypotheses     Volume:  -     ISSN:  1532-2777     ISO Abbreviation:  -     Publication Date:  2011 Jul 
Date Detail:
Created Date:  2011-7-26     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7505668     Medline TA:  Med Hypotheses     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2011. Published by Elsevier Ltd.
Department of Cardiology, West China Hospital of Sichuan University, Chengdu, Sichuan 610041, China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Arsenic oxide targets stem cell marker CD133/prominin-1 in gallbladder carcinoma.
Next Document:  Application of tissue microarray for atherectomized tissues from peripheral arterial disease.